Products

EN

CN EN

mRNA Vaccine

The mRNA vaccine has the characteristics of "self-adjuvant", shows strong immunogenicity, does not require viruses and unique antigen expression, which is safer and has a shorter production cycle and more flexibility than traditional vaccines. In the downstream production of mRNA vaccines, Lisure can help with reducing production costs and improve production efficiency.

Step 1

Step 2

Step 3

Step 4

Single-use bioreactor

Explore more

Hollow fiber ultrafiltration system

Explore more

Inline alkaline lysis system

Explore more

Clarification and filtration system

Explore more

Single-use mixer

Explore more

Chrom system/column

Explore more

Chrom system/column

Explore more

Chrom system/column

Explore more

Chrom system/column

Explore more

Chrom system/column

Explore more

Membrane ultrafiltration system

Explore more

T-tube/microfluidic control system

Explore more

Sterilizing filtration system

Explore more

Adjuvant prep equipment

Explore more

Pre-mix and packaging

Explore more

mRNA vaccine

Explore more